查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1387430

牛流行病熱 (BEF) 疫苗市場報告：2030 年趨勢、預測和競爭分析

Bavine Ephermal Fever Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

牛流行病熱 (BEF) 疫苗趨勢和預測

預計 2024 年至 2030 年，全球牛流行病熱 (BEF) 疫苗市場將以 7.0% 的年複合成長率成長。該市場的主要促進因素是偶發性牛熱病例數量的增加、疫苗生產技術的發展以及製藥公司需求的增加。全球牛流行病熱（BEF）疫苗市場前景廣闊，醫療設備公司、製藥業、獸醫院市場蘊藏商機。

牛流行病熱 (BEF) 疫苗市場洞察

Lucintel 預測，由於世界範圍內偶發性牛的高發生率和牛的數量，牛在預測期內將經歷最大的成長。

由於許多公司大力投資獸用疫苗的研發，預計北美在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球牛流行病（BEF）疫苗市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球牛流行病（BEF）疫苗市場趨勢（2018-2023）及預測（2024-2030）
  • 按類型分類的全球牛流行病熱 (BEF) 疫苗市場
    • 活病毒疫苗
    • 去活化疫苗
    • 其他
  • 全球牛流行病熱 (BEF) 疫苗市場（按應用）
    • 牛
    • 水牛
    • 其他
  • 全球牛流行病熱 (BEF) 疫苗市場（按最終用途）
    • 醫療設備公司
    • 製藥業
    • 動物醫院
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球牛流行病熱（BEF）疫苗市場區域分佈
  • 北美牛流行病（BEF）疫苗市場
  • 歐洲牛流行病熱（BEF）疫苗市場
  • 亞太地區牛流行病（BEF）疫苗市場
  • 其他地區牛流行病（BEF）疫苗市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球牛流行病熱 (BEF) 疫苗市場成長機會（按類型）
    • 全球牛流行病熱 (BEF) 疫苗市場成長機會（按應用）
    • 全球牛流行病熱 (BEF) 疫苗市場成長機會（按最終用途）
    • 全球牛流行病熱（BEF）疫苗市場成長機會（按地區）
  • 全球牛流行病熱（BEF）疫苗市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球牛流行病熱 (BEF) 疫苗市場產能擴張
    • 全球牛流行病熱（BEF）疫苗市場的合併、收購與合資
    • 認證和許可

第7章 主要企業概況

  • Zoetis Services
  • Nutri Pharmax
  • Octavoscene
  • Kyoto Biken Laboratories
  • Indian Immunologicals
簡介目錄

Bavine Ephermal Fever Vaccine Trends and Forecast

The future of the global bavine ephermal fever vaccine market looks promising with opportunities in the medical device companies, pharmaceutical industries, and animal hospitals markets. The global bavine ephermal fever vaccine market is expected to grow with a CAGR of 7.0% from 2024 to 2030. The major drivers for this market are growing number of cases of transient bovine fever, technological developments in the creation of vaccines , and rising demand for pharmaceutical companies.

A more than 150-page report is developed to help in your business decisions.

Bavine Ephermal Fever Vaccine by Segment

The study includes a forecast for the global bavine ephermal fever vaccine by type, application, end use, and region.

Bavine Ephermal Fever Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Live Vaccines
  • Killed Vaccines
  • Others

Bavine Ephermal Fever Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cattle
  • Water Buffaloes
  • Others

Bavine Ephermal Fever Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Medical Device Companies
  • Pharmaceutical Industries
  • Animal Hospitals
  • Others

Bavine Ephermal Fever Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Bavine Ephermal Fever Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bavine ephermal fever vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bavine ephermal fever vaccine companies profiled in this report include-

  • Zoetis Services
  • Nutri Pharmax
  • Octavoscene
  • Kyoto Biken Laboratories
  • Indian Immunologicals

Bavine Ephermal Fever Vaccine Market Insights

Lucintel forecasts that cattle is expected to witness largest growth over the forecast period due to high prevalence of bovine ephemeral fever in cattle and large population of cattle worldwide.

North America is expected to witness largest growth over the forecast period due to growing presence of large number of companies with large investment of research and development of vaccines for animal health care.

Features of the Global Bavine Ephermal Fever Vaccine Market

Market Size Estimates: Bavine ephermal fever vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Bavine ephermal fever vaccine market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Bavine ephermal fever vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, end use, and regions for the bavine ephermal fever vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bavine ephermal fever vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for bavine ephermal fever vaccine market?

Answer: The global bavine ephermal fever vaccine market is expected to grow with a CAGR of 7.0% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the bavine ephermal fever vaccine market?

Answer: The major drivers for this market are growing number of cases of transient bovine fever, technological developments in the creation of vaccines , and rising demand for pharmaceutical companies.

Q3. What are the major segments for bavine ephermal fever vaccine market?

Answer: The future of the global bavine ephermal fever vaccine market looks promising with opportunities in the medical device companies, pharmaceutical industries, and animal hospitals markets.

Q4. Who are the key bavine ephermal fever vaccine market companies?

Answer: Some of the key bavine ephermal fever vaccine companies are as follows:

  • Zoetis Services
  • Nutri Pharmax
  • Octavoscene
  • Kyoto Biken Laboratories
  • Indian Immunologicals

Q5. Which bavine ephermal fever vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that cattle is expected to witness largest growth over the forecast period due to high prevalence of bovine ephemeral fever in cattle and large population of cattle worldwide.

Q6. In bavine ephermal fever vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness largest growth over the forecast period due to growing presence of large number of companies with large investment of research and development of vaccines for animal health care.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the bavine ephermal fever vaccine market by type (live vaccines, killed vaccines, and others), application (cattle, water buffaloes, and others), end use (medical device companies, pharmaceutical industries, animal hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bavine Ephermal Fever Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Bavine Ephermal Fever Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Bavine Ephermal Fever Vaccine Market by Type
    • 3.3.1: Live Vaccines
    • 3.3.2: Killed Vaccines
    • 3.3.3: Others
  • 3.4: Global Bavine Ephermal Fever Vaccine Market by Application
    • 3.4.1: Cattle
    • 3.4.2: Water Buffaloes
    • 3.4.3: Others
  • 3.5: Global Bavine Ephermal Fever Vaccine Market by End Use
    • 3.5.1: Medical Device Companies
    • 3.5.2: Pharmaceutical Industries
    • 3.5.3: Animal Hospitals
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Bavine Ephermal Fever Vaccine Market by Region
  • 4.2: North American Bavine Ephermal Fever Vaccine Market
    • 4.2.2: North American Bavine Ephermal Fever Vaccine Market by End Use: Medical Device Companies, Pharmaceutical Industries, Animal Hospitals, and Others
  • 4.3: European Bavine Ephermal Fever Vaccine Market
    • 4.3.1: European Bavine Ephermal Fever Vaccine Market by Application: Cattle, Water Buffaloes, and Others
    • 4.3.2: European Bavine Ephermal Fever Vaccine Market by End Use: Medical Device Companies, Pharmaceutical Industries, Animal Hospitals, and Others
  • 4.4: APAC Bavine Ephermal Fever Vaccine Market
    • 4.4.1: APAC Bavine Ephermal Fever Vaccine Market by Application: Cattle, Water Buffaloes, and Others
    • 4.4.2: APAC Bavine Ephermal Fever Vaccine Market by End Use: Medical Device Companies, Pharmaceutical Industries, Animal Hospitals, and Others
  • 4.5: ROW Bavine Ephermal Fever Vaccine Market
    • 4.5.1: ROW Bavine Ephermal Fever Vaccine Market by Application: Cattle, Water Buffaloes, and Others
    • 4.5.2: ROW Bavine Ephermal Fever Vaccine Market by End Use: Medical Device Companies, Pharmaceutical Industries, Animal Hospitals, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Bavine Ephermal Fever Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global Bavine Ephermal Fever Vaccine Market by Application
    • 6.1.3: Growth Opportunities for the Global Bavine Ephermal Fever Vaccine Market by End Use
    • 6.1.4: Growth Opportunities for the Global Bavine Ephermal Fever Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Bavine Ephermal Fever Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Bavine Ephermal Fever Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bavine Ephermal Fever Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Zoetis Services
  • 7.2: Nutri Pharmax
  • 7.3: Octavoscene
  • 7.4: Kyoto Biken Laboratories
  • 7.5: Indian Immunologicals